CJC-1295 DAC – 5mg

CJC-1295 DAC 5mg is supplied for laboratory and scientific research purposes.

Axis Therapies provides high purity research peptides manufactured in Australia, produced in controlled laboratory settings in Sydney with a focus on consistency and batch traceability.
CJC-1295 DAC is a synthetic peptide analogue commonly studied in research relating to growth hormone releasing hormone pathways, peptide signalling, and endocrine system interaction models. The DAC component is frequently referenced in laboratory research exploring extended peptide activity and albumin binding behaviour within controlled experimental environments.

Each vial is produced to high purity standards, with batch referenced testing available where applicable.

Purity: ≥99%
Form: Lyophilised powder
Strength: 5mg per vial
Quantity: Sold per vial
Manufactured in Australia (Sydney)
Testing: COA available for selected batches
This product is supplied strictly for laboratory research use only. Not for human or veterinary use.